AstraZeneca PLC (AZN)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 210.69B |
| Enterprise value | 233.45B |
| Trailing P/E | 35.88 |
| Forward P/E | 16.23 |
| PEG ratio (5-yr expected) | 0.87 |
| Price/sales (ttm) | 4.66 |
| Price/book (mrq) | 5.41 |
| Enterprise value/revenue | 5.10 |
| Enterprise value/EBITDA | 17.39 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.19 |
| 52-week change 3 | -9.58% |
| S&P500 52-week change 3 | 21.23% |
| 52-week high 3 | 76.56 |
| 52-week low 3 | 60.47 |
| 50-day moving average 3 | 66.08 |
| 200-day moving average 3 | 66.62 |
Share statistics
| Avg vol (3-month) 3 | 6.27M |
| Avg vol (10-day) 3 | 5.81M |
| Shares outstanding 5 | 3.1B |
| Implied shares outstanding 6 | 3.12B |
| Float 8 | 1.54B |
| % held by insiders 1 | 0.00% |
| % held by institutions 1 | 16.81% |
| Shares short (28 Mar 2024) 4 | 7.66M |
| Short ratio (28 Mar 2024) 4 | 1.61 |
| Short % of float (28 Mar 2024) 4 | N/A |
| Short % of shares outstanding (28 Mar 2024) 4 | 0.25% |
| Shares short (prior month 29 Feb 2024) 4 | 9.26M |
Dividends & splits
| Forward annual dividend rate 4 | 1.45 |
| Forward annual dividend yield 4 | 2.12% |
| Trailing annual dividend rate 3 | 2.90 |
| Trailing annual dividend yield 3 | 4.23% |
| 5-year average dividend yield 4 | 2.52 |
| Payout ratio 4 | 76.12% |
| Dividend date 3 | 25 Mar 2024 |
| Ex-dividend date 4 | 22 Feb 2024 |
| Last split factor 2 | 2:1 |
| Last split date 3 | 27 July 2015 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 13.00% |
| Operating margin (ttm) | 16.92% |
Management effectiveness
| Return on assets (ttm) | 6.60% |
| Return on equity (ttm) | 15.64% |
Income statement
| Revenue (ttm) | 45.81B |
| Revenue per share (ttm) | 2.45 |
| Quarterly revenue growth (yoy) | 7.30% |
| Gross profit (ttm) | N/A |
| EBITDA | 15.01B |
| Net income avi to common (ttm) | 5.95B |
| Diluted EPS (ttm) | 1.91 |
| Quarterly earnings growth (yoy) | 6.50% |
Balance sheet
| Total cash (mrq) | 5.86B |
| Total cash per share (mrq) | 3.78 |
| Total debt (mrq) | 29.65B |
| Total debt/equity (mrq) | 75.70% |
| Current ratio (mrq) | 0.82 |
| Book value per share (mrq) | 25.25 |
Cash flow statement
| Operating cash flow (ttm) | 10.34B |
| Levered free cash flow (ttm) | 9.5B |
© 2024 Yahoo. All rights reserved.